Oral Oncology Drugs Rife With Challenges

Pharmacy Practice News

Los Angeles—In recent years, oral oncology agents have flooded the market, providing new therapeutic options. Although these drugs are seen as more convenient for patients, they come with a unique set of challenges, according to a panel of experts at the 2013 annual meeting of the Hematology/Oncology Pharmacy Association.

Food–drug and drug–drug interactions, limited access, reimbursement problems and monitoring requirements are all obstacles associated with oral cancer drugs, said panelist Robert Ignoffo, PharmD, a professor of pharmacy at Touro University California and a clinical professor emeritus at the University of California, San Francisco.

Continue reading this article on the Pharmacy Practice News website.